A retrospective study analysing prevalence of spondyloarthritis associated disease under vedolizumab treatment for inflammatory bowel disease
Latest Information Update: 18 Feb 2021
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
- 18 Feb 2021 New trial record
- 12 Feb 2021 Results published in the Rheumatology